Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys, Inc. (NASDAQ: AMED) is a healthcare at home company that reports on developments across home health, hospice and high acuity care services delivered in the home. The Amedisys news flow includes regular earnings announcements, corporate updates and clinical program disclosures that reflect its role in the home health care services industry.
Investors and observers following AMED news can expect detailed quarterly and annual financial results, including net service revenue, net income, adjusted EBITDA and other non-GAAP measures that Amedisys reconciles to GAAP in its releases. These earnings communications often discuss factors such as merger-related expenses, impairment charges and other items that affect reported and adjusted results.
Amedisys also issues news about its clinical initiatives and partnerships. For example, the company has announced the rollout of advanced molecular testing for infection diagnosis in collaboration with Patient Choice Laboratories, aimed at improving the speed and accuracy of identifying pathogens in urine, respiratory and wound infections in the home setting. Through its subsidiary Contessa Health, Amedisys has highlighted participation in models such as the Centers for Medicare & Medicaid Services’ GUIDE Model for dementia care, reflecting activity in alternative payment and care delivery models.
Other Amedisys news items cover recognition for patient and caregiver satisfaction, such as SHPBest™ awards for home health and hospice care centers, and updates related to its merger with UnitedHealth Group, including regulatory and legal milestones. Readers who monitor AMED news gain insight into the company’s financial performance, regulatory environment, care quality indicators and the evolution of its home-based service offerings.
Amedisys, Inc. (NASDAQ: AMED) has successfully acquired regulatory assets enabling it to conduct home health care operations in Westchester County, NY. The agreement grants Amedisys the right to operate certified home health care services in Westchester and the Bronx, with plans to establish a care center catering to approximately 375,000 Medicare and 165,000 Medicare Advantage enrollees. This expansion reinforces Amedisys's position as a significant player in the aging-in-place sector.
Amedisys, Inc. (NASDAQ: AMED) will report its second quarter results for the period ending June 30, 2021, on August 4, 2021. An investor conference call is scheduled for August 5, 2021, at 11:00 a.m. ET to discuss these results. Participants can call in using the numbers provided, and a replay will be available until September 5, 2021. Amedisys is a leading healthcare provider offering home health, hospice, and personal care, serving over 418,000 patients annually with approximately 21,000 employees across 514 care centers in 39 states and D.C.
Amedisys has completed its acquisition of Visiting Nurse Association (VNA), expanding its home health and hospice services in Omaha, Nebraska, and Council Bluffs, Iowa. This strategic move aims to enhance Amedisys' capacity to care for more patients by leveraging VNA's legacy. Amedisys will provide services through Amedisys Home Health and AseraCare Hospice, while VNA will continue its community-focused programs. The acquisition supports Amedisys' goal to deliver comprehensive care at home, reflecting its commitment to improving health services in these regions.
Amedisys has announced a definitive agreement to acquire Contessa Health, a leader in hospital-at-home and skilled nursing at home services. This strategic acquisition will enhance Amedisys's capabilities by adding advanced analytics and risk management, while significantly expanding its total addressable market from $44B to $73B. The deal positions Amedisys as the first major home health provider to operate in this high-acuity care space, reflecting an increasing trend for patients to receive care in familiar environments. The transaction is set to close in summer 2021, pending regulatory approvals.
Amedisys, a leading home health, hospice, and personal care company, announces presentations by key executives Paul B. Kusserow, Chris Gerard, and Scott Ginn at significant upcoming conferences. They will be presenting at the William Blair Growth Stock Conference on June 3, 2021, at 1:00 p.m. ET, and at the Jefferies Virtual Healthcare Conference on June 4, 2021, at 9:00 a.m. ET. Amedisys serves over 418,000 patients annually through its extensive network of care centers across the U.S., focusing on personalized healthcare solutions.
Amedisys, a leading home health and hospice company, has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare. This annual recognition honors 150 organizations that empower employees to deliver quality care. Amedisys' CEO and HR Chief highlighted the importance of a supportive culture, especially during the pandemic, contributing to reduced turnover and enhanced employee engagement. The full ranking will be released on September 16, 2021.
Amedisys (NASDAQ: AMED) is set to transition home health and hospice operations from the Visiting Nurse Association (VNA) on July 1, 2021. This move aligns with VNA's mission to focus on community needs amid evolving healthcare demands. Amedisys aims to enhance its resources and scale, thereby expanding service access in Nebraska and Iowa. VNA will continue offering essential community programs, ensuring that underserved individuals receive care through Amedisys’ existing services.
Amedisys, a prominent home healthcare company, is set to present at the 2021 RBC Capital Markets Healthcare Conference on May 18, 2021. The presentation will be delivered by Paul B. Kusserow, CEO, and Chris Gerard, COO, starting at 1:20 p.m. Eastern Time. Interested investors can access the live webcast through Amedisys' investor website. Founded in 1982, Amedisys operates 514 care centers across 39 states, delivering high-quality home health, hospice, and personal care services to over 418,000 patients annually.
Summary not available.
Amedisys, Inc. (NASDAQ: AMED), a prominent provider of home health, hospice, and personal care, has successfully completed its acquisition of regulatory assets enabling operations in Randolph County, N.C. This acquisition allows Amedisys to offer certified home health care services to a market of 31,000 Medicare and Medicare Advantage enrollees. Amedisys plans to establish a start-up care center in the area, further expanding its services and reinforcing its position as a leader in home-based health care.